Keyphrases
Protective Immunity
100%
Toxoplasma Gondii (T. gondii)
100%
Cyclophilin A
100%
Recombinant BCG Vaccine
100%
Expression Plasmid
66%
T. Gondii Infection
66%
Survival Rate
33%
Immunization
33%
Virulence Factors
33%
Human Vaccines
33%
Interleukin-12 (IL-12)
33%
Inoculation
33%
Immunogenic
33%
Balb C Mice
33%
Immunopathology
33%
CD4+
33%
CD8+ T Cells
33%
Improved Survival
33%
Catalytic Activity
33%
Interleukin-2
33%
Mycobacterium Bovis
33%
Survival Time
33%
Target Antigen
33%
Recombinant Plasmid
33%
Toxoplasmosis
33%
Oral Route
33%
Time Rate
33%
Integrative Expression
33%
Protection Efficiency
33%
Live Vaccine Vector
33%
Immunology and Microbiology
Plasmid
100%
Mycobacterium Bovis BCG
100%
BCG Vaccine
100%
Toxoplasma gondii
100%
Survival Rate
50%
Adjuvant
50%
Virulence Factor
50%
T-Helper Cell
50%
Attenuated Vaccine
50%
Live Vaccine
50%
Genetic Transfection
50%
Bagg Albino Mouse
50%
Cytotoxic T-Cell
50%
Immunopathology
50%
Interleukin 2
50%
Mycobacterium bovis
50%
Survival Time
50%
Recombinant Plasmid
50%
Toxoplasmosis
50%